Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: NJR stock price vs NHI: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at NHI's multiple
Needs NHI P/E.
Implied fair value · at NJR's multiple
Needs NJR P/E.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: NJR FY 2025 (ended Sep 30, 2025) · NHI FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Ten fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 61% equity / 39% debt · EV / Revenue 6.56x · EV / EBITDA 15.75x
Capital structure 74% equity / 26% debt · EV / Revenue 12.55x · EV / EBITDA 18.52x
NJR carries the larger enterprise value at $8.86B against $4.71B; NJR trades on the lower EV / Revenue multiple (6.56x vs 12.55x); NJR on the lower EV / EBITDA (15.75x vs 18.52x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
NEW JERSEY RESOURCES CORPORATION · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
National Health Investors, Inc. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
1.44x
0.82x
Net debt / EBITDA
Leverage against operating earnings
6.12x
4.85x
Cash and equivalents
Liquid reserves on the balance sheet
$591.00K
$19.62M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
$3.45B
$1.25B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
